Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Post by investforever1on Apr 14, 2022 1:29pm
249 Views
Post# 34604409

New Vice Chairman Welcome to the NEW ERA for ASP

New Vice Chairman Welcome to the NEW ERA for ASP Dr. Samuel Herschkowitz, M.D., is the founder of Serenity Pharmaceuticals and has served as CEO since 2007. He is a Clinical Professor at New York University Medical Center and has served on academic positions with Beth Israel Hospital, Mount Sinai Medical School and Downstate Medical Center. He is also a founder of several other health care companies and presently sits on several boards of directors. Dr. Herschkowitz is board certified in psychiatry and neurology, and he has been a fellow in immunology at Sloan Kettering Memorial Hospital. He obtained a Bachelor of Arts from Syracuse University in 1971 and received his medical degree from State University of New York Downstate Medical Center in 1976.
<< Previous
Bullboard Posts
Next >>